Literature DB >> 23329428

The authors' reply to wonder and milne: "comparing subsidized access to medicines across payer systems".

Rajan Ragupathy, Katri Aaltonen, June Tordoff, Pauline Norris, David Reith.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23329428     DOI： 10.1007/s40273-012-0014-5

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  4 in total

1.  Access to new medicines in New Zealand compared to Australia.

Authors:  Michael Wonder; Richard Milne
Journal:  N Z Med J       Date:  2011-11-25

2.  Key informants' perceptions of how pharmac operates in New Zealand.

Authors:  Rajan Ragupathy; June Tordoff; Pauline Norris; David Reith
Journal:  Int J Technol Assess Health Care       Date:  2012-10       Impact factor: 2.188

3.  A 3-dimensional view of access to licensed and subsidized medicines under single-payer systems in the US, the UK, Australia and New Zealand.

Authors:  Rajan Ragupathy; Katri Aaltonen; June Tordoff; Pauline Norris; David Reith
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

4.  The impact of pharmaceutical cost containment policies on the range of medicines available and subsidized in Finland and New Zealand.

Authors:  Katri Aaltonen; Rajan Ragupathy; June Tordoff; David Reith; Pauline Norris
Journal:  Value Health       Date:  2009-09-10       Impact factor: 5.725
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.